Overview

ATTIC - Access To Treat in the Community

Status:
Recruiting

Trial end date:
2021-03-01

Target enrollment:

Participant gender:

Summary

The study is looking at the potential of utilizing a "point of care" test and treat pathway; using the DDA called Zepatier for achieving SVR in an homeless population who have tested positive for genotype 1 or 4 HCV.

Phase:

Phase 4

Details

Lead Sponsor:

King's College Hospital NHS Trust

Collaborators:

Hepatitis C Trust
Merck Sharp & Dohme Corp.

Treatments:

Elbasvir-grazoprevir drug combination